{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:06:13Z","timestamp":1777467973268,"version":"3.51.4"},"reference-count":20,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,11,10]]},"DOI":"10.18632\/oncotarget.6062","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T01:26:06Z","timestamp":1445217966000},"page":"37995-38004","source":"Crossref","is-referenced-by-count":16,"title":["Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell\/nevoid subpopulations and assists in microstaging of human melanoma"],"prefix":"10.18632","volume":"6","author":[{"given":"Jonathan J.","family":"Lee","sequence":"first","affiliation":[{"name":"Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Royal Surrey County Hospital, Guildford, United Kingdom"},{"name":"Cancer Research UK, Manchester Institute, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Mihm","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyun","family":"Xu","sequence":"additional","affiliation":[{"name":"Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhan","sequence":"additional","affiliation":[{"name":"Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Wang","sequence":"additional","affiliation":[{"name":"Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George F.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine G.","family":"Lian","sequence":"additional","affiliation":[{"name":"Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,9]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/modpathol.3800516","article-title":"Unusual variants of malignant melanoma","volume":"19","author":"Mihm","year":"2006","journal-title":"Mod Pathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2133.2006.07570.x","article-title":"Melanomas arising from naevi and de novo melanomas\u2014does origin matter?","volume":"156","author":"Lawrence","year":"2007","journal-title":"Br J Dermatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jdermsci.2013.09.008","article-title":"5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi","volume":"73","author":"Okuyama","year":"2014","journal-title":"J Dermatol Sci"},{"key":"4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CMR.0b013e32835f9bd4","article-title":"Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma","volume":"23","author":"Skrygan","year":"2013","journal-title":"Melanoma Res"},{"key":"5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00509234","article-title":"Nevoid malignant melanoma","volume":"277","author":"Braun-Falco","year":"1985","journal-title":"Arch Dermatol Res"},{"key":"6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jcp.53.8.591","article-title":"Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis","volume":"53","author":"Coburn","year":"2000","journal-title":"J Clin Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/00000478-200012000-00003","article-title":"Malignant melanoma with paradoxical maturation","volume":"24","author":"Shea","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/modpathol.2013.224","article-title":"Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors","volume":"27","author":"Lian","year":"2014","journal-title":"Mod Pathol"},{"key":"10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cell.2013.12.019","article-title":"Reversing DNA methylation: mechanisms, genomics, and biological functions","volume":"156","author":"Zhang","year":"2014","journal-title":"Cell"},{"key":"11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/labinvest.2014.87","article-title":"Melanoma epigenetics: novel mechanisms, markers, and medicines","volume":"94","author":"Lian","year":"2014","journal-title":"Lab Invest"},{"key":"12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/modpathol.2014.99","article-title":"5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies","volume":"28","author":"Lian","year":"2015","journal-title":"Mod Pathol"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/cup.12564","article-title":"Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations","author":"Taube","year":"2015","journal-title":"J Cutan Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.18632\/oncotarget.316","article-title":"Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem\/progenitor cell compartments and in human","volume":"2","author":"De Marzo","year":"2011","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/carcin\/bgu140","article-title":"Identification of a melanoma susceptibility locus and somatic mutation in TET2","volume":"35","author":"Duffy","year":"2014","journal-title":"Carcinogenesis"},{"key":"16","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/cancers3021672","article-title":"Role of gene methylation in antitumor immune response: implication for tumor progression","volume":"3","author":"Redondo","year":"2011","journal-title":"Cancers"},{"key":"17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1101\/gad.217406.113","article-title":"What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer","volume":"27","author":"Kaelin","year":"2013","journal-title":"Genes Dev"},{"key":"18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alphaketoglutarate-dependent dioxygenases","volume":"19","author":"Liu","year":"2011","journal-title":"Cancer Cell"},{"key":"19","first-page":"443","article-title":"Melanoma's connections to the tumour microenvironment","volume":"45","author":"Haass","year":"2013","journal-title":"Pathology"},{"key":"20","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1038\/jid.2013.115","article-title":"Hypoxia contributes to melanoma heterogeneity by triggering HIF1alpha dependent phenotype switching","volume":"133","author":"Levesque","year":"2013","journal-title":"J Invest Dermatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T23:15:54Z","timestamp":1599693354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,9]]},"references-count":20,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2015,11,10]]}},"alternative-id":["6062","26462027"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6062","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,9]]}}}